Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase NA 5Phase 2 1

Status

Completed 5Unknown 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Conditions

Neoplasms 2012Carcinoma, Non-Small-Cell Lung 1228Breast Neoplasms 1215Leukemia, Myeloid, Acute 967Neoplasm Metastasis 902Melanoma 778Colorectal Neoplasms 752Multiple Myeloma 725Lymphoma 725Ovarian Neoplasms 675Pancreatic Neoplasms 665Lymphoma, Non-Hodgkin 659Prostatic Neoplasms 657Recurrence 637Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Lung Neoplasms 560Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 486Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 419Brain Neoplasms 415Squamous Cell Carcinoma of Head and Neck 389Stomach Neoplasms 387Carcinoma, Renal Cell 385Myelodysplastic Syndromes 382Carcinoma, Hepatocellular 368Advanced Solid Tumors 357Lymphoma, Mantle-Cell 345Glioma 343

Interventions

Rosuvastatin Calcium 2technetium 99m HYNIC-duramycin 1eltrombopag 1darolutamide 1Cell Death 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Healthy Volunteers × Clear all
NCT01961869 2025-11-20

Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers

Ohio State University Comprehensive Cancer Center

Phase 1 Unknown
67 enrolled

Healthy Volunteers

NCT06471712 2025-09-08

Clinical Study of 18F-LNC1007 Injection PET/CT

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 1 Completed
8 enrolled

Healthy Volunteers

NCT06463782 2025-09-03

Clinical Study of 68Ga-LNC1007 Injection PET/CT

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 1 Completed
8 enrolled

Healthy Volunteers

NCT04542382 2025-03-30

BCRPmarker

University of California, San Francisco

Phase 1 Completed
11 enrolled

Healthy Volunteers

NCT05177640 2022-01-27

PicTURE

University Hospital, Antwerp

Phase 1 Completed
6 enrolled

Healthy Volunteers

NCT02671097 2016-09-08

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Bayer

Phase 1 Completed
30 enrolled

Healthy Volunteers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡